secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allakos Inc. (—)
CIK:        0001564824
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001140361-25-019156
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allakos acquired by Concentra Biosciences for $0.33/share; delisting from Nasdaq
--------------------------------------------------------------------------------

- Allakos acquired by Concentra Biosciences via tender offer and merger for $0.33 per share in cash.
- Approximately 81.21% of outstanding shares tendered; all conditions satisfied.
- Merger completed May 15, 2025; Allakos now a wholly owned subsidiary of Concentra.
- Allakos board and officers resigned; replaced by Kevin Tang and other Concentra executives.
- Trading of ALLK shares suspended; company to file Form 25 to delist and deregister.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/0001140361-25-019156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1564824/000114036125019156/ny20049047x1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-019156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer